Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.

Name: Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.
Author: Schreiber, Anna R

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models. — المؤلف: Schreiber, Anna R — Clinical cancer drugs 2018

المؤلف: Schreiber, Anna R
النشر: Clinical cancer drugs 2018
الوصف: 42-49 p.